Salari and GHLV is the real deal.
We are making consistent progress forward and now we are getting into production in North America!!!
IMHO, they are poising themselves for a buyout. Production is in place and the only obstacle at this point is FDA approval. Since they are going for molecular likeness of Viagra, rather than being a brand new drug, the approval process should be much quicker and easier to navigate.
Salari was recently in the EU on business dealings and I wonder if he was either A. Discussing partnership opportunities with big pharma or B. working on setting up production in EU.
This is a HUGE industry and this offering is getting a huge headstart in a generic game. I think GHLV is going to be gobbled up by big pharma real soon.